It is generally accepted that in a normal woman during her reproductive years, only a few follicles develop and mature in each cycle, of which only one follicle undergoes ovulation, while the rest of the equally mature follicles do not ovulate and degenerate. When anovulation is caused by dysfunction of the hypothalamic-pituitary-ovarian axis, it can lead to infertility. The induction of ovulation is an important step in the infertility treatment process for patients with anovulation. The effectiveness of ovulation induction can directly affect the quality and quantity of eggs, and thus the final outcome of pregnancy. It is important to carefully select the ovulation-promoting drugs and protocols for each patient. Ovulation-promoting drugs that are often used include clomiphene, chorionic gonadotropin, urotropin, luteinizing hormone-releasing hormone, and bromocriptine. Regardless of the regimen, there are different groups of people who are suitable for ovulation, so it is important to listen to the advice of a professional doctor when choosing one. The side effects of ovulation-promoting drugs are more obvious and may lead to ovarian hyperstimulation syndrome, menstrual irregularities, premature ovarian failure, etc. It is not recommended that patients use ovulation-promoting drugs at their own discretion. These medications should only be used with caution and under the guidance of a doctor when indicated.